.png?width=600&height=300&name=TEG%20FDA%20COVID-19%20Policy%20600x300%20(002).png)
In compliance with the recent FDA Guidance on Viscoelastic Testing During the COVID-19 Public Health Emergency, the Instructions For Use addenda for our TEG® 5000 and TEG® 6s products are provided below.
TEG 5000 Instructions for Use addendum
TEG 6s Instructions for Use addendum
FDA Guidance on Viscoelastic Testing During the COVID-19 Public Health Emergency
© 2021 Haemonetics Corporation. Haemonetics and TEG are trademarks or registered trademarks of Haemonetics Corporation in the USA, other countries or both. 02.2021 USA. COL-COPY-001495-US(AA)